PNEUMOCYSTOSIS ASSOCIATED WITH AIDS
Clinical trials for PNEUMOCYSTOSIS ASSOCIATED WITH AIDS explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTOSIS ASSOCIATED WITH AIDS trials appear
Sign up with your email to follow new studies for PNEUMOCYSTOSIS ASSOCIATED WITH AIDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Study seeks best backup plan for dangerous pneumonia when standard drug fails
Disease control Not yet recruitingThis study aims to find the best alternative treatment for a serious lung infection called PCP pneumonia in people with weakened immune systems. It focuses on patients who cannot take the usual first-choice antibiotic due to allergies, side effects, or because it doesn't work for…
Matched conditions: PNEUMOCYSTOSIS ASSOCIATED WITH AIDS
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Trial challenges 3-Week steroid rule for deadly pneumonia
Disease control Not yet recruitingThis study aims to find the best length of steroid treatment for adults with weakened immune systems who have a severe lung infection called PCP. It will compare stopping steroids after 10 days (if the patient has recovered enough) to the standard 21-day course. The goal is to se…
Matched conditions: PNEUMOCYSTOSIS ASSOCIATED WITH AIDS
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC